LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

DCL Medical Laboratories Sold to Laboratory Corporation of America

By LabMedica International staff writers
Posted on 28 Jul 2010
Thompson Street Capital Partners (St. Louis, MO, USA) have sold DCL Medical Laboratories, LLC (DCL) to Laboratory Corporation of America Holdings (LabCorp; Burlington, NC, USA), a U.S. provider of medical laboratory tests and services. Terms of the transaction were not disclosed.

DCL provides diagnostic and clinical trial testing services to physicians, hospitals, and pharmaceutical and medical device companies. The company provides anatomic pathology as well as clinical trial testing services and specializes in women's health.

LabCorp offers clinical assays ranging from routine blood analysis to HIV and genomic testing. DCL will join LabCorp's nationwide network of 38 primary testing locations and its industry-leading Centers of Excellence laboratories, including the Center for Esoteric Testing, Viro-Med, National Genetics Institute and US Labs.

In 2007, Thompson Street, together with Jack Bergstrom and Jay Tyler, acquired DCL from its founders. The goal of the transaction was to capitalize and expand the company's strong reputation in women's health. Thompson Street's managing partner, Jim Cooper, said, "We achieved this by growing our sales force and laboratory staff, increasing our participation in pharmaceutical and medical device clinical trials, and investing in our laboratory IT and test equipment infrastructure."

Related Links:
Thompson Street Capital Partners
Laboratory Corporation of America Holdings


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Automated Clinical Chemistry Analyzer
Envoy 500+

Latest Industry News

New NHS Partnership Expands Access to Epigenetic CNS Tumor Classifiers
28 Jul 2010  |   Industry

Fujirebio Expands Access to Automated Blood-Based Neurology Testing in Canada
28 Jul 2010  |   Industry

Natera ctDNA Test to Support Response Monitoring in Solid Tumor Trial
28 Jul 2010  |   Industry